Matikas A - Search Results

1

Grading the evidence for physical activity and any outcome in cancer survivors: An Umbrella review of 740 meta-analytic associations.

Filis P, Markozannes G, Chan DS, Mauri D, Foukakis T, Matikas A, Droufakou S, Pentheroudakis G, Tsilidis K. Filis P, et al. Among authors: matikas a. Crit Rev Oncol Hematol. 2025 Mar;207:104602. doi: 10.1016/j.critrevonc.2024.104602. Epub 2024 Dec 25. Crit Rev Oncol Hematol. 2025. PMID: 39730034 Free article. Review.

2

The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic review.

Filis P, Zerdes I, Soumala T, Matikas A, Foukakis T. Filis P, et al. Among authors: matikas a. Crit Rev Oncol Hematol. 2023 Dec;192:104189. doi: 10.1016/j.critrevonc.2023.104189. Epub 2023 Oct 21. Crit Rev Oncol Hematol. 2023. PMID: 37866413 Free article.

3

Tackling endocrine resistance in ER-positive HER2-negative advanced breast cancer: A tale of imprecision medicine.

Matikas A, Foukakis T, Bergh J. Matikas A, et al. Crit Rev Oncol Hematol. 2017 Jun;114:91-101. doi: 10.1016/j.critrevonc.2017.04.002. Epub 2017 Apr 7. Crit Rev Oncol Hematol. 2017. PMID: 28477750 Review.

4

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis.

Zhu Y, Tzoras E, Matikas A, Bergh J, Valachis A, Zerdes I, Foukakis T. Zhu Y, et al. Among authors: matikas a. Front Oncol. 2022 Nov 30;12:999843. doi: 10.3389/fonc.2022.999843. eCollection 2022. Front Oncol. 2022. PMID: 36531050 Free PMC article.

5

The interplay between eosinophils and T cells in breast cancer immunotherapy.

Zerdes I, Matikas A, Foukakis T. Zerdes I, et al. Among authors: matikas a. Mol Oncol. 2023 Apr;17(4):545-547. doi: 10.1002/1878-0261.13413. Epub 2023 Mar 17. Mol Oncol. 2023. PMID: 36892326 Free PMC article.

6

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.

Matikas A, Foukakis T, Bergh J. Matikas A, et al. Acta Oncol. 2017 Sep;56(9):1143-1151. doi: 10.1080/0284186X.2017.1329593. Epub 2017 May 24. Acta Oncol. 2017. PMID: 28537808 Review.

7

RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.

Matikas A, Foukakis T, Bergh J. Matikas A, et al. J Natl Cancer Inst. 2018 Nov 1;110(11):1280-1281. doi: 10.1093/jnci/djy046. J Natl Cancer Inst. 2018. PMID: 29618043 No abstract available.

8

SOLAR1s: alpelisib returns to earth?

Matikas A, Foukakis T. Matikas A, et al. Ann Oncol. 2021 Feb;32(2):129-132. doi: 10.1016/j.annonc.2020.12.003. Epub 2020 Dec 9. Ann Oncol. 2021. PMID: 33309744 Free article. No abstract available.

9

Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis.

Boman C, Zerdes I, Mårtensson K, Bergh J, Foukakis T, Valachis A, Matikas A. Boman C, et al. Among authors: matikas a. Cancer Treat Rev. 2021 Sep;99:102257. doi: 10.1016/j.ctrv.2021.102257. Epub 2021 Jul 1. Cancer Treat Rev. 2021. PMID: 34237488 Free article.

10

Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236.

Filis P, Salgkamis D, Matikas A, Zerdes I. Filis P, et al. Among authors: matikas a. Drug Discov Today. 2025 Jan;30(1):104250. doi: 10.1016/j.drudis.2024.104250. Epub 2024 Nov 24. Drug Discov Today. 2025. PMID: 39586491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters